Panoptica's Series A Round

Panoptica raised a round of funding on December 27, 2010.

PanOptica is a private biopharmaceutical company focused on licensing and developing innovative ophthalmology therapies. PanOptica has identified and evaluated more than 200 biopharmaceutical assets w…

Articles about Panoptica's Series A Round: